Lupin Blood Pressure Medication Recall Due To Cancer Concerns
According to Forbes.com, Lupin Pharmaceuticals Inc. has announced the recall of all its irbesartan tablets and their irbesartan plus hydrochlorothiazide (HCTZ) tablets. The recall was initiated due to the discovery of a potentially cancer-causing impurity, N-nitrosoirbesartan, in several lots of Lupin's irbesartan plus … [Read more...] about Lupin Blood Pressure Medication Recall Due To Cancer Concerns
Irbesartan and Irbesartan plus Hydrochlorothiazide Recalls
Lupin Pharmaceuticals Recalls All Irbesartan Tablets and Irbesartan & Hydrochlorothiazide Tablets Due to the Presence of N-nitrosoirbesartan, a Known Human Carcinogen WASHINGTON, D.C. - On October 14, 2021, the U.S. Food and Drug Administration announced Lupin Pharmaceuticals, Inc. had initiated a recall of its Irbesartan … [Read more...] about Irbesartan and Irbesartan plus Hydrochlorothiazide Recalls
